Hi All.
Just doing a bit of light reading and have come to the conclusion ( Rightly or wrongly) Happy to be corrected by the more learned among us!
Given the two snippets of information from Management . Am I correct in ASSUMING that on a annual basis at the moment that we can safely assume that we are close US10M per annum just on US Mattress sales alone ?
STRATEGIC & COMMERCIAL VALUE
Cooling technologies for bedding applications has been a strategic focus for the Company and represents
+90% of product sales to date. Given our strong brand identity and product value proposition here, a
strategic initiative for the Company is to increase our market penetration. Internal market analyses
supported by published market reports value the total addressable market for cooling technology in
mattresses at +US$30M per annum. For this specific TMCS, the company values the near-term target
market at +US$2M per annum. To drive this market penetration, the TMCS paradigm has been integral
to this strategic initiative. This integration of cooling technologies in a mattress system allows the
Company to leverage its IP and analytical capabilities and to increase our revenue per unit through
inclusion of multiple Alexicool® products in each unit. The Company anticipates further growth in this
market through additional TMCS designs based on other proprietary technologies such as Phonon.
Alexium PCM products have achieved
+30% market share for textile applications
for mattresses in US market.
Happy to hear from all.
Have a great day
H
- Forums
- ASX - By Stock
- Ann: Half Year Presentation
AJX
alexium international group limited
Add to My Watchlist
0.00%
!
0.8¢

Hi All.Just doing a bit of light reading and have come to the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.69M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1521039 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 3117282 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1521039 | 0.007 |
4 | 710906 | 0.006 |
3 | 849000 | 0.005 |
2 | 570000 | 0.004 |
1 | 700000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 3117282 | 3 |
0.009 | 2460714 | 4 |
0.010 | 285705 | 2 |
0.011 | 1510000 | 3 |
0.012 | 116000 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online